| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.68 | 0.01 |